ADAR1 Capital Management »

Embrace Change Acquisitn Cor shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Embrace Change Acquisitn Cor (EMCGW) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Embrace Change Acquisitn Cor

Tip: Access up to 7 years of quarterly data

All positions including Embrace Change Acquisitn Cor held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Embrace Change Acquisitn Cor by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $406 18k 0.02
2023-12-31 $234 18k 0.01

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Embrace Change Acquisitn Cor

Clear Street
Atw Spac Management
Polar Securities
Wolverine Asset Management
Context Capital Management
Hudson Bay Capital Management
Weiss Asset Management LP[1
CNH Partners
Shaolin Capital Management
Taconic Capital Advisors
Periscope Capital
Cowen And Company
Schechter Investment Advisors
D. E. Shaw & Co
Cable Car Capital

View all funds holding Embrace Change Acquisitn Cor